title: Enhancement of allograft survival by donor-specific transfusion one day prior to transplant. Importance of timing and specificity when DST is given with cyclosporine.
abstract: Donor-specific transfusion effects were studied in the ACI-to-Lewis rat heterotopic heart allograft model using cyclosporine immunosuppression. Low-dose CsA for 1 week plus a single fresh or stored DST given 1 day before allografting significantly prolonged graft survival over CsA therapy alone (median survival time 23.5 days vs. 10 days, P less than 0.01), but third-party transfusion did not (11.5 vs. 10 days, NS). When CsA was started at the time of DST and continued for 2 weeks, maximal graft enhancement was achieved after just one DST. DST/CsA was equally efficacious if given on any day before transplantation, provided CsA was started on the same day as the transfusion. However, pretransplant DST given without CsA shortened subsequent graft survival of day -1 DST/CsA treatment (14.5 days, n = 6, vs. 60 days for controls, n = 10; P less than 0.01). The addition of methylprednisolone to the DST/CsA protocol had no effect on graft survival (51 vs. 53 days, P = NS), but extending the period of postoperative CsA therapy for 4 weeks at reduced dose (2.5 mg/kg/day) significantly prolonged median survival (111 days, n = 11) and resulted in 45% permanent engraftment (greater than 120 days survival). CsA permits graft enhancement with a single DST as early as 1 day before grafting. This avoids the risk of sensitization from DSTs and can extend DST use to cadaveric graft recipients.
authors.affiliation: Department of Surgery, University of Florida College of Medicine, Gainesville 32610-0286.
authors.forename: M E
authors.initials: ME
authors.lastname: Brunson
authors.forename: J I
authors.initials: JI
authors.lastname: Tchervenkov
authors.forename: J W
authors.initials: JW
authors.lastname: Alexander
mesh_terms: D000818:Animals; D001803:Blood Transfusion; D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D000939:Epitopes; D006085:Graft Survival; D016027:Heart Transplantation; D007165:Immunosuppression Therapy; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D003524:Cyclosporins; D000939:Epitopes